November 14, 2025 · Form 4 insider transaction
LEIDEN JEFFREY M sold 40 shares of Vertex Pharmaceuticals Incorporated at $442.00 per share, a transaction worth $17.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 8/6/2025.